Top-News
Google
Newsfile  | 
aufrufe Aufrufe: 86

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Blueprint Medicines Corporation (BPMC)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Blueprint Medicines Corporation ("Blueprint" or the "Company") (NASDAQ - BPMC) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Sanofi for $129.00 per share in cash at closing, representing an equity value of approximately $9.1 billion. Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) which will entitle the holder to receive two potential milestone payments of $2 and $4 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. The total (Total Aktie) equity value of the transaction, including potential CVR payments, represents approximately $9.5 billion on a fully diluted basis.

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Medicines -   Medicines Chart 0,00%
Zugehörige Wertpapiere:

The investigation concerns whether the Blueprint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

If you own shares of Blueprint stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at clients@brodsky-smith.com, visit https://www.brodskysmith.com/cases/blueprint-medicines-corporation-nasdaq-bpmc/, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254235

Für dich aus unserer Redaktion zusammengestellt

Dein Kommentar zum Artikel im Forum

Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend